Slenfig 15 mg Capsule belongs to the class of medication called anti-obesity drugs used to treat obesity and help lose weight. Slenfig 15 mg Capsule is recommended for obese patients with an initial body mass index (BMI) ≥ 30 kg/m2 or ≥ 27 kg/m2 in the presence of other risk factors (e.g., dyslipidemia or Abnormally elevated cholesterol or fats, diabetes, controlled hypertension). Slenfig 15 mg Capsule should be used along with a low-calorie diet and regular physical exercise. Obesity is a medical condition caused by excess body fat, making a person overweight and predisposing them to many conditions and disorders. Intake of more calories than you burn by exercise or daily activities results in obesity.

Slenfig 15 mg Capsule contains Sibutramine which causes weight loss by suppressing the appetite and promoting energy expenditure.

Take Slenfig 15 mg Capsule as prescribed by your doctor. You are advised to take Slenfig 15 mg Capsule for as long as your doctor has prescribed it for you based on your condition. Some people may experience dry mouth, headache, loss of appetite, trouble sleeping, and constipation. Most of these side effects of Slenfig 15 mg Capsule do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.

Slenfig 15 mg Capsule is contraindicated in patients with hypersensitivity to Sibutramine or any of the inactive ingredients in it. Slenfig 15 mg Capsule is contraindicated in patients receiving monoamine oxidase inhibitors (MAOIs) or other centrally acting weight loss drugs. It is recommended not to use in patients with a major eating disorder (anorexia nervosa or bulimia nervosa). The use of Slenfig 15 mg Capsule during pregnancy and breastfeeding is not recommended. The efficacy of Sibutramine in adolescents who are obese has not been adequately studied. The concomitant use of Slenfig 15 mg Capsule and excess alcohol is not recommended.

Slenfig 15 mg Capsule contains Sibutramine, an anti-obesity drug indicated for managing obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a reduced-calorie diet. Slenfig 15 mg Capsule is recommended for obese patients with an initial body mass index (BMI) ≥ 30 kg/m2 or ≥ 27 kg/m2 in the presence of other risk factors (e.g., dyslipidemia or Abnormally elevated cholesterol or fats, diabetes, controlled hypertension). Sibutramine causes weight loss by suppressing the appetite and by promoting energy expenditure. Slenfig 15 mg Capsule should be used along with a low-calorie diet and regular physical exercise. Thus, Slenfig 15 mg Capsule promotes weight loss and lowers the possibility of developing major health issues.

• Dry mouth
• Headache
• Loss of appetite
• Trouble sleeping
• Constipation

If you have an allergy to any ingredient in Slenfig 15 mg Capsule , it is advised that you avoid using it. While taking Slenfig 15 mg Capsule , women who are sexually active should use effective contraception. Patients should be instructed to inform their doctor immediately if they get pregnant or plan to get pregnant while taking Slenfig 15 mg Capsule . Sibutramine or its metabolites may be excreted in human milk; however, this is unknown. Therefore, using Slenfig 15 mg Capsule while breastfeeding is not advised. Since there is little knowledge on utilizing Slenfig 15 mg Capsule in teens, it is advised against doing so. Inform your doctor about your medical history and the other drugs you are currently taking before taking Slenfig 15 mg Capsule to rule out any possible side effects or interactions.

Drug-Drug Interactions: Slenfig 15 mg Capsule may interact with monoamine oxidase inhibitors or antidepressants (e.g. isocarboxazid, phenelzine, citalopram, clomipramine, doxepin), medicines used to prevent nausea and vomiting in certain conditions (e.g. ondansetron), medicines used to treat the symptoms of migraine headaches (e.g. sumatriptan) and other centrally acting weight loss drugs (e.g. merastin).

Drug-Food Interactions: Avoid high-fat meals and alcoholic beverages.

Drug-Disease Interactions: Slenfig 15 mg Capsule may interact with disease conditions, including anorexia nervosa (An eating disorder), cardiovascular disorders, glaucoma (eye conditions that can cause blindness) and renal/liver disease.

• ISOCARBOXAZID
• PHENELZINE
• CITALOPRAM
• CLOMIPRAMINE
• DOXEPIN
• ONDANSETRON
• SUMATRIPTAN
• MERASTIN

• Maintain a low-fat diet. Prefer skim milk and fat-free or low-fat dairy products.
• Avoid red meat and include lean meat such as salmon and chicken.
• Eat a healthy diet that includes fruits, vegetables, lean protein and whole grains.
• Avoid fried foods, fast food, instant food, pasta, burger, noodles and cookies.
• Limit your sugar intake, as excess sugar is stored as fat in the body.
• Do not skip meals to reduce weight but instead, take balanced meals.
• Do regular exercise such as swimming, cycling, walking or dancing for a minimum of 20 to 30 minutes daily.
• Avoid alcohol consumption.

Obesity: Obesity is a common condition associated with excessive body fat, which in turn increases the risk of other health problems such as diabetes, high blood pressure, certain cancers and heart disease. Intake of more calories than you burn by exercise or daily activities results in obesity. Some common causes of obesity include insufficient sleep, growing older, pregnancy, genetics, hypothyroidism (underactive thyroid gland) or polycystic ovary syndrome (imbalance of female reproductive hormones). Proper diet and exercise are advised, along with medication to treat obesity.